Pharmaceutical Grade Polydeoxyribonucleotide (PDRN) is a high-purity biopolymer derived from controlled extraction processes.
Pharmaceutical Grade Polydeoxyribonucleotide (PDRN) is a highly purified biopolymer composed of defined DNA fragments derived from biological sources. Presented in a lyophilized powder form, it enables precise dosing and reproducible outcomes in tissue regeneration research and pharmaceutical development. Key technical attributes include a tightly controlled molecular weight distribution and validated purity, achieved through advanced extraction, purification, and analytical methodologies. These characteristics minimize batch-to-batch variability, supporting accurate biochemical investigations and reliable in-vitro cellular assays.
|
Parameter |
Specification |
|
Product Name |
Pharmaceutical Grade Polydeoxyribonucleotide (PDRN) |
|
INCI Name |
Hydrolyzed DNA |
|
Source |
Derived from Salmon Sperm DNA |
|
Appearance |
White to off-white lyophilized powder |
|
Assay (PDRN Content) |
≥ 95.0% (by UV spectrophotometry) |
|
Molecular Weight Range |
50 kDa – 300 kDa (by Size Exclusion Chromatography) |
|
Solubility |
Freely soluble in water and aqueous solutions |
|
pH (1% aqueous solution) |
6.0 – 7.5 |
|
Loss on Drying |
≤ 5.0% |
Note: The above specifications are based on theoretical parameters and are subject to batch-to-batch variation. Please refer to the certificate of analysis for actual data.
Pharmaceutical Grade PDRN is supplied in moisture-resistant, airtight containers with an additional foil liner to prevent contamination and protect against environmental exposure. Each package includes desiccant packets to maintain low-humidity conditions during transit and storage. Recommended storage conditions are a cool, dry environment, protected from light. Custom packaging options, including alternate container sizes and labeling, are available upon request to accommodate specific laboratory and handling requirements.